戈壁创投庄汉彬：从“时、地、人”维度评估项目，坚定担任领投方

Core Insights - Gobi Partners is focusing on early-stage investments in sectors like biotechnology, AI, and robotics through its newly established Gobi-RIF fund, collaborating with Hong Kong University of Science and Technology and Hong Kong Investment Company [1][3] - The firm emphasizes its role as a lead investor, particularly in high-tech projects with unclear business models, leveraging its extensive experience and academic networks to assess the commercial viability of startups [6][10] Investment Strategy - Gobi Partners evaluates early-stage projects based on three dimensions: time, location, and team [7] - The time dimension focuses on whether the technology has reached a commercialization threshold and if market conditions are favorable [8] - The location dimension assesses the suitability of the startup's development in specific regions, particularly in Hong Kong and Greater Bay Area [8] - The team dimension prioritizes the founder's learning ability and the overall team's research capabilities [8] Collaboration and Support - The partnership with Hong Kong University and Hong Kong Investment Company aims to enhance the commercialization of university-incubated projects, providing early access to potential investments [4][5] - Gobi Partners plays a proactive role in connecting startups with resources, facilitating communication among founders, and assisting in government funding applications [9] Market Environment - The Hong Kong IPO market has seen a resurgence, with total fundraising exceeding HKD 210 billion in 2025, marking a four-year high, which provides a favorable exit environment for venture capital [3][10] - The introduction of listing rules 18A and 18C has created clearer pathways for biotech and long-cycle enterprises to go public, enhancing the investment timeline for venture capitalists [10][11]